Clinical Investigations

Slides:



Advertisements
Similar presentations
What FDA Looks for When Inspecting IRBs and Sponsors Marian J. Serge Nurse Consultant Division of Bioresearch Monitoring Office of Compliance Center for.
Advertisements

Tips to a Successful Monitoring Visit
Single-Patient Use of Investigational Drugs and Biologic Products for Treating Cancer Grant Williams, M.D. Medical Team Leader DODP/CDER/FDA.
Managing Regulatory Documents Electronically
RESEARCH COMPLIANCE Agenda 1. No Destruction of local research documents after scanning 2. Training for shipping biological samples/specimens 3. Regulatory.
The IND and Clinical Trial Management Frances Richmond Director International Center for Clinical Trials.
Special Topics in IND Regulation
November 10, Office of Research Administration: Clinical Research Contracting Presented to: Research Administration Professionals Group Patricia.
Human Investigation Committee  Is it research?  If yes, does it involve human subjects?  If yes, can it be exempt?  If no, will a Request for.
Ethical Principles of Human Subjects Protection
1 Developed by: U-MIC To start the presentation, click on this button in the lower right corner of your screen. The presentation will begin after the.
Stanley Estime, MSCI December 9, 2014 Record Keeping: What is Regulatory Documentation and how should it be maintained? Tel:
Overview of Good Clinical Practices (GCPs)
Coordinator University Clinical Research Pharmacy Investigational Drug Service (IDS) Marjorie Shaw Phillips, MS, RPh, FASHP Clinical Research Pharmacist.
GW OFFICE OF HUMAN RESEARCH IRB FORUM JULY 2015 NEW FORMS AND POLICIES.
Special Issues in FDA-Regulated Studies: The Good, the Bad, and the Ugly C. Karen Jeans, MSN, CCRN, CIP COACH Program Analyst VA Office of Research & Development.
Prof. Moustafa M. Mohamed Vice dean Faculty of Allied Medical Science Pharos University in Alexandria Development and Regulation of Medical Products (MEDR-101)
THE UNIVERSITY OF NEW MEXICO ▪ HEALTH SCIENCES CENTER Clinical and Translational Science Center (CTSC) 4/2009.
Role of the Oncology Research Team Carmen B. Jacobs, RN, OCN, CCRP.
 Understanding the IRB Process University of Tennessee Health Science Center Institutional Review Board.
Investigational New Drug Application (IND)
Institutional Review Board (IRB) for Human Subject Protections: Working with the IRB Erin McClure, PhD Department of Psychiatry and Behavioral Sciences.
When do I need an IND ? FDA Guidance for Industry – Investigation New Drug Applications (INDs) - Determining Whether Human Research Studies Can Be Conducted.
University of Miami Office of Research Compliance Assessment Lynn E. Smith, JD, CIM, CIP Johanna Stamates, RN, BA, CCRC With assistance from Elizabeth.
© 2009 Cengage Learning. All Rights Reserved. Clinical Research.
PATRICIA KERBY, MPA HUMAN SUBJECTIONS PROTECTION COMPLIANCE OFFICER OFFICE OF RESEARCH COMPLIANCE What are the FDA’s expectations in 2010?
Read the SMALL PRINT of the 1572 The Essential GCP Document.
MEDICAL experts INDUSTRY Some of our clients. Pharmaceutical companies, manufacturers of medical and surgical devices, clinical research organizations,
Paula Peyrani, MD Division of Infectious Diseases University of Louisville The IRB Process What do I need to know? The IRB Process.
UC DAVIS OFFICE OF RESEARCH Overview of Good Clinical Practices (GCP) Investigator and Study Team Responsibilities Miles McFann IRB Administration Training.
Privacy vs. Confidentiality.  IRB review of privacy and confidentiality protections is required under the Common Rule and the FDA regulations, as well.
QSR and GLP What exactly are these?.
Process of FDA New Drug Approval: 1- New Compound with promising preclinical data 2- Sponsor applies to FDA for an IND (Investigational New Drug Application)
Welcome New IRB Members! Today we will discuss: Your Role in the IRB: What to Know The IRB Review Process Resources Human Research Protections.
Human Subjects Research Office of Responsible Research Practices Human Subjects Research Vanessa Hill, MSHS, CCRC Senior Quality Improvement Specialist.
Health Insurance portability and Accountability Act (HIPAA)‏
Module C FDA Regulations Regulatory Documents Patricia E. Koziol 1Module C Final Version 10-apr-2010.
Stanley Estime, MSCI October 19, 2015 Record Keeping: What is Regulatory Documentation and how should it be maintained? Tel:
HIPAA and Human Subjects Research IRB Member CE May 2014 Slideshow by Sean Horkheimer.
Welcome New IRB Member! This brief presentation covers: Your Role in the IRB: What to Know The IRB Review Process Resources Human Research Protections.
HUD and Emergent Use Walter Kraft. Device Classification Significant risk – Often involve an invasive procedure for implantation or use – Requires IDE.
INVESTIGATOR RESPONSIBILITIES C. Karen Jeans, MSN COACH Project Analyst.
Data Management – Regulatory Binder By: Johanna Park
Drug Development and IND Process GC 690 Walter Kraft, MD.
Using A Central IRB At Thomas Jefferson University / Hospital Roseann Talarico Associate Director Office of Human Research.
Lifespan GOOD CLINICAL PRACTICE Record Management GCP May 2005.
Institutional Review Board (IRB) for Human Subject Protections: Working with the IRB Erin A McClure, PhD Department of Psychiatry and Behavioral Sciences.
IRB University is a set of classes aimed at helping the research community become familiar with submission requirement and the IRB process. Classes are.
1 IND Applications for Academic Clinical Investigations John Marler, MD US Food and Drug Administration New Hampshire Avenue White Oak, MD
IRB BASICS BETTY WILSON, MS, CIP. CONCEPTS SUBMISSION APPROVAL RECRUITING WORKING WITH PRINCIPAL INVESTIGATOR (PI) /SPONSOR POLICIES DEVIATIONS RECORD.
Cancer Clinical Trials Office Clinical Trials & Research Training Oct2014.
Clinicaltrials.gov Update
Beverley Alberola, CIP Associate Director, Research Protections
Data Management – Regulatory Binder
Alyssa Speier, MS, CIP November 13, 2013
Welcome New IRB Members!
REDCap Regulatory Binder
Roles and Responsibilities of the Clinical Research Team
Regulatory Binder: Maintaining Essential Study Documentation
Top Ten eIRB Application Mistakes
Elements of an Organized Regulatory Binder
Sponsor Expectations for Clinical Studies
To start the presentation, click on this button in the lower right corner of your screen. The presentation will begin after the screen changes and you.
Streamlining IRB Procedures for Expanded Access
FDA Medical Device Approval Pathways
Bringing Clarity to IRB Correspondence
Case Study Retrospective review of patient’s medical record with intent to document a specific situation or the experience of an individual without intent.
Retrospective Chart Review
Making Your IRBs and Clinical Investigators HIPAA-Ready
Opening an IND: Investigator Perspective
Presentation transcript:

Clinical Investigations Experiments using a test article on one or more human subjects that are regulated by the Food and Drug Administration or support applications for research or marketing permits for products regulated by the Food and Drug Administration. Products regulated include foods (dietary supplements that bear a nutrient content claim or a health claim, infant formulas, food and color additives), drugs for human use, medical devices for human use, biological products for human use, and electronic products. IRB determination required. Documents: Protocol Template HRP-503 Sponsor’s Protocol Investigator’s brochure FDA status of drug (IND or Exemption) Delegation of Authority Log Consent Template HRP-502 Assent Template HRP-500 (if applicable) Sponsor’s Consent Templates Form FDA 1572 IDIR HRP-508 HIPAA Authorization Template HRP-502.1 Questionnaires, surveys or other assessments Research Study Administrative Record HRP-585 Cost Analysis CITI training complete COI Disclosure complete Contract in signature phase Recruitment materials (if applicable)